| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |
| 04/02/2009 | US20090087428 Anti-fc-gamma riib receptor antibody and uses therefor |
| 04/02/2009 | US20090087427 Biological materials and uses thereof |
| 04/02/2009 | US20090087426 Methods for Treatment of Allergic Asthma |
| 04/02/2009 | US20090087423 Novel protein complex and use thereof |
| 04/02/2009 | US20090087404 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 04/02/2009 | US20090087403 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 04/02/2009 | US20090087382 Contrast agents and methods for preparing contrast agents |
| 04/02/2009 | CA2704134A1 Monoclonal antibodies to respiratory syncytial virus and uses thereof |
| 04/02/2009 | CA2701668A1 Factor involved in latent infection with herpesvirus, and use thereof |
| 04/02/2009 | CA2701072A1 Materials and methods relating to modifying the binding of antibodies |
| 04/02/2009 | CA2700986A1 Anti-glypican-3 antibody having improved kinetics in plasma |
| 04/02/2009 | CA2700945A1 Nucleotide triphosphate with an electroactive label conjugated to the gamma phosphate |
| 04/02/2009 | CA2700815A1 Optimized nucleic acid sequences for the expression of vb4-845 |
| 04/02/2009 | CA2700810A1 Immunoliposomes for treatment of cancer |
| 04/02/2009 | CA2700723A1 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins |
| 04/02/2009 | CA2700714A1 Dual specificity antibody fusions |
| 04/02/2009 | CA2700701A1 Method of modifying isoelectric point of antibody via amino acid substitution in cdr |
| 04/02/2009 | CA2700498A1 Anti-il-6 receptor antibody |
| 04/02/2009 | CA2700481A1 Antigen binding proteins |
| 04/02/2009 | CA2700394A1 Modified antibody constant region |
| 04/02/2009 | CA2700365A1 Benzoquinone derivative e3330 in combination with chemotherapeutic agents for the treatment of cancer and angiogenesis |
| 04/02/2009 | CA2700351A1 Fixed single injection dosage for ocrelizumab (2h7) |
| 04/02/2009 | CA2700129A1 Vaccines and vaccine components for inhibition of microbial cells |
| 04/02/2009 | CA2698609A1 Novel antibodies |
| 04/02/2009 | CA2697583A1 Antidotes for factor xa inhibitors and methods of using the same |
| 04/01/2009 | EP2042868A1 Immunochromatographic test device |
| 04/01/2009 | EP2042603A1 Phosphonate metabolizing plants |
| 04/01/2009 | EP2042597A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 04/01/2009 | EP2042596A1 Polypeptides involved in immune response |
| 04/01/2009 | EP2042594A1 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 04/01/2009 | EP2042518A2 Dual specificity antibodies and methods of making and using |
| 04/01/2009 | EP2042517A1 Optimized FC variants and methods for their generation |
| 04/01/2009 | EP2042512A2 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 04/01/2009 | EP2042509A1 Modulators of the function of FAS receptors and other proteins |
| 04/01/2009 | EP2042196A2 Remodelling and glycoconjugation of Granulocyte Colony Stimulating Factor (G-CSF) |
| 04/01/2009 | EP2042194A2 Treatment of refractory human tumors with epidermal growth factor receptor antagonists |
| 04/01/2009 | EP2041574A2 Cancer biomarkers and methods of use threof |
| 04/01/2009 | EP2041182A1 Framework selection |
| 04/01/2009 | EP2041181A1 Specific protease inhibitors and their use in cancer therapy |
| 04/01/2009 | EP2041180A2 Ilt3 binding molecules and uses therefor |
| 04/01/2009 | EP2041179A2 Antigenic surface structure of sperm cells associated with the y chromosome |
| 04/01/2009 | EP2041178A2 Single-chain multivalent binding proteins with effector function |
| 04/01/2009 | EP2041177A2 High affinity antibodies to human il-6 receptor |
| 04/01/2009 | EP2041175A1 Targeted immune conjugates |
| 04/01/2009 | EP1994163A4 Inhibition of breast carcinoma stem cell growth and metastasis |
| 04/01/2009 | EP1835926A4 Plasmin-inhibitory therapies |
| 04/01/2009 | EP1774023A4 Markers for brain damage |
| 04/01/2009 | EP1585984B1 Diagnostic methods for protein profiling |
| 04/01/2009 | EP1549341B1 Tissue factor targeted antibodies as anticoagulants |
| 04/01/2009 | EP1446425B1 Treatment of micro-organism infection |
| 04/01/2009 | EP1427825B1 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | EP1153139B1 Polymorphic markers of the lsr gene |
| 04/01/2009 | EP1119623B1 Mage-a3 peptides presented by hla class ii molecules |
| 04/01/2009 | EP0847452B1 Monoclonal antibody for inhibiting hiv-1 envelope glycoprotein mediated membrane fusion |
| 04/01/2009 | CN101400703A Domain antibody construct |
| 04/01/2009 | CN101400702A Method for the production of antibodies in immunodeficient animal injected with human fetal liver stem cells |
| 04/01/2009 | CN101400701A Growth inhibitory composition against pathogenic bacteria of meat based food stuff comprising igy |
| 04/01/2009 | CN101397564A Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 04/01/2009 | CN101397551A Neukinase and its use in treatment of cardiovascular disease |
| 04/01/2009 | CN101397342A Anti-schistosoma japonicum monoclonal antibody NP11-4 chimeric Fab antibody, preparation method and use |
| 04/01/2009 | CN101397340A Basic orange artificial antigen synthesis and antibody preparation method |
| 04/01/2009 | CN101397336A Antigenic Neisserial peptides |
| 04/01/2009 | CN101397335A Particles of HCV envelope proteins: use for vaccination |
| 04/01/2009 | CN101397334A Anti-human cytomegalovirus gBn1 antibody, preparation method and special antigen |
| 04/01/2009 | CN100473725C Bacillus thuringiensis Cry ET 33 and Cry ET 34 compositions and uses therefor |
| 04/01/2009 | CN100473665C H5 subtype avian flu virus hemagglutinin protein monoclonal antibody, and preparing method and use thereof |
| 04/01/2009 | CN100473664C Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 04/01/2009 | CN100473417C Method of modulating memory effector T-cells using CD2-binding agent, and compositions |
| 03/31/2009 | US7511124 immunoconjugate and duramycin-based compositions and combinations that bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases; kits |
| 03/31/2009 | US7511123 Binding to antigen; controlling concentration |
| 03/31/2009 | US7511122 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511017 Inhibiting apoptosis associated with HIV infection; immunoglobulin constant domain heterologous polypeptide; isolated nucleic acid encoding a human polypeptide, tumor necrosis factor receptor-5 |
| 03/31/2009 | US7511012 Myostatin binding agents |
| 03/31/2009 | US7510874 Stable cell lines expressing HERG1a and HERG1b |
| 03/31/2009 | US7510855 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510847 Drug screening for compound having uricosuric regulating action by incubating a transformed cell expressing a recombinant protein with uric acid; and determining an uptake of uric acid; gout |
| 03/31/2009 | US7510843 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 03/31/2009 | US7510840 Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibody |
| 03/31/2009 | US7510838 Methods and compositions for the detection of cervical disease |
| 03/31/2009 | US7510713 Administering monoclonal antibody secific to lymphocyte peripheral membrane protein for treating and preventing transplant rejection, blood, skin, autoimmune, allergic and diabetic disorders |
| 03/31/2009 | US7510712 Administering a monoclonal anti-CD80 antibody or CD80 binding fragment that binds specifically to human CD80 antigen and inhibits binding of the CD80 antigen to CD28 without inhibiting the binding of the CD80 antigen to CTLA-4; immunosuppressants, autoimmune diseases, transplant rejection |
| 03/31/2009 | US7510711 Nucleotide sequence coding monoclonal antibody; anticancer agents; antiinflammatory agents; immunology disorders |
| 03/31/2009 | US7510710 Etomoxir and a 2-deoxy-D-glucose compound; antiinflammatory, antiproliferative, anticarcinogenic and wound healing agents; drug resistant cancers |
| 03/31/2009 | US7510709 Method of treating inflammatory disease by inhibition of IL-17 production |
| 03/31/2009 | CA2192467C Calcium binding recombinant antibody against protein c |
| 03/31/2009 | CA2066204C Cystic fibrosis gene |
| 03/29/2009 | CA2704064A1 Humanized antibodies against the .beta.-amyloid peptide |
| 03/26/2009 | WO2009039507A2 Identification and isolation of fetal cells and nucleic acid |
| 03/26/2009 | WO2009039414A2 Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| 03/26/2009 | WO2009039413A2 Methods and compositions for detection of ehrlichia chaffeensis (p120) |
| 03/26/2009 | WO2009039337A2 Inhibition of angiogenesis |
| 03/26/2009 | WO2009038760A2 Human gm-csf antigen binding proteins |
| 03/26/2009 | WO2009038689A2 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 03/26/2009 | WO2009037525A1 Nucleotide and protein sequences of an antibody directed against an epitope common to human acidic and basic ferritins, monoclonal antibodies or antibody-like molecules comprising these sequences and use thereof |
| 03/26/2009 | WO2009037402A2 Hpiv-2 variants and medical applications thereof |
| 03/26/2009 | WO2009037297A2 Method for the preparation of new oligoclonal antibodies |